Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma.

Autor: Granell M; Hematology Department, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain. mgranell@santpau.cat., Senín A; Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Badalona, Spain., Barata A; Hematology Department, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain. anna.barata@moffitt.org.; Health Outcomes and Behavior Department, Moffitt Cancer Center, Tampa, FL, US. anna.barata@moffitt.org., Cibeira MT; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Gironella M; Hematology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain., López-Pardo J; Hematology Department, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Motlló C; Hematology Department, Hospital Sant Joan de Déu Manresa, Barcelona, Spain., Garcia-Guiñón A; Hematology Department, Hospital Universitari Arnau de Vilanova, Lleida, Spain., Ben-Azaiz R; Hematology Department, Hospital del Mar-IMIM, Universitat Autònoma de Barcelona, Barcelona, Spain., Abella E; Hematology Department, Hospital del Mar-IMIM, Universitat Autònoma de Barcelona, Barcelona, Spain., Soler A; Hematology Department, Hospital Universitari Parc Taulí Sabadell, Barcelona, Spain., Canet M; Hematology Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain., Martí JM; Hematology Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain., Martino R; Hematology Department, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Sierra J; Hematology Department, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., de Larrea CF; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Oriol A; Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Badalona, Spain., Rosiñol L; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2021 Dec; Vol. 56 (12), pp. 2904-2910. Date of Electronic Publication: 2021 Aug 17.

Study of the frequency and reasons for discontinuation of different lines of treatment in patients with multiple myeloma.

Autor: Senín A; Hematology Department, Hospital del Mar-IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Universidad Autónoma de Barcelona, Barcelona, Spain. 60014@parcdesalutmar.cat., García-Pallarols F; Hematology Department, Hospital del Mar-IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Universidad Autónoma de Barcelona, Barcelona, Spain., Ben Azaiz R; Hematology Department, Hospital del Mar-IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Universidad Autónoma de Barcelona, Barcelona, Spain., Martínez-Serra L; Hematology Department, Hospital del Mar-IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Universidad Autónoma de Barcelona, Barcelona, Spain., Montesdeoca S; Hematology Department, Hospital del Mar-IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Universidad Autónoma de Barcelona, Barcelona, Spain., Román D; Hematology Department, Hospital del Mar-IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Universidad Autónoma de Barcelona, Barcelona, Spain., Ferraro M; Hematology Department, Hospital del Mar-IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Universidad Autónoma de Barcelona, Barcelona, Spain., Párraga I; Hematology Department, Hospital del Mar-IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Universidad Autónoma de Barcelona, Barcelona, Spain., Besses C; Hematology Department, Hospital del Mar-IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Universidad Autónoma de Barcelona, Barcelona, Spain., Abella E; Hematology Department, Hospital del Mar-IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Universidad Autónoma de Barcelona, Barcelona, Spain.

Publikováno v: Annals of hematology [Ann Hematol] 2019 Mar; Vol. 98 (3), pp. 705-711. Date of Electronic Publication: 2019 Jan 23.

Post-Transplant Complications in Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT)—A Comparative Analysis of Home Care versus Hospitalized Patients.

Autor: Garcés-Carrasco, Ana María, Santacatalina-Roig, Enric, Carretero-Márquez, Carlos, Chover-Sierra, Elena, Martínez-Sabater, Antonio, Balaguer-López, Evelin

Publikováno v: Medicina (1010660X); Jan2024, Vol. 60 Issue 1, p44, 10p

Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: results from a historical cohort, Brazil 2009-2020.

Autor: Teixeira MX; Department of Social Pharmacy, Federal University of Minas Gerais - UFMG, Avenida Antônio Carlos, 6627 - Pampulha, Belo Horizonte, MG, Brazil., Reis AMM; Department of Pharmaceutical Products, Federal University of Minas Gerais - UFMG, Belo Horizonte, Brazil., Drummond PLM; Department of Social Pharmacy, Federal University of Minas Gerais - UFMG, Avenida Antônio Carlos, 6627 - Pampulha, Belo Horizonte, MG, Brazil.; Ezequiel Dias Foundation - Funed, Belo Horizonte, Brazil., Malta JS; Department of Social Pharmacy, Federal University of Minas Gerais - UFMG, Avenida Antônio Carlos, 6627 - Pampulha, Belo Horizonte, MG, Brazil., Silveira LP; Department of Social Pharmacy, Federal University of Minas Gerais - UFMG, Avenida Antônio Carlos, 6627 - Pampulha, Belo Horizonte, MG, Brazil.; Hospital das Clínicas da UFMG, Belo Horizonte, Brazil., Menezes de Pádua CA; Department of Social Pharmacy, Federal University of Minas Gerais - UFMG, Avenida Antônio Carlos, 6627 - Pampulha, Belo Horizonte, MG, Brazil. campadua@farmacia.ufmg.br.

Publikováno v: Annals of hematology [Ann Hematol] 2024 Mar 09. Date of Electronic Publication: 2024 Mar 09.